CRITICAL CARE CLINICS重症监护临床
CRITICAL CARE CLINICS(英文缩写 CRIT CARE CLIN),ISSN 0749-0704,eISSN 1557-8232,中文译名:重症监护临床 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-27 至 2026-09-27，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 3.879 | Q2 |
| 2022 | 4.300 | Q2 |
| 2023 | 3.000 | Q2 |
| 2024 | 2.400 | Q2 |
| 2025 | 3.000 | Q2 |
CRITICAL CARE CLINICS 最新收录文献
-
1. Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.
PMID:日期:2026-07-01该文献暂无摘要。
-
2. Advances and Challenges in Sepsis Care in Low-Resource Settings.
PMID:日期:2026-07-01Sepsis is a leading cause of death worldwide, disproportionately affecting low-resource settings. Limited diagnostics, antimicrobial resistance, and scarce critical care capacity compound the burden. Areas for improved care include physiology-based triage, point-of-care lactate testing, and simplified severity scores for early recognition. Context-specific strategies favor cautious fluid resuscitation, safe peripheral vasopressor use, improved oxygen systems, and portable ultrasound for monitoring and source control. Expanding access to microbiology and tailored antimicrobial stewardship remain critical. Sustainable progress depends on workforce training, system strengthening, and context-appropriate guidelines. Locally driven research and global investment are essential to achieve equity in sepsis care delivery.
-
3. The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.
PMID:日期:2026-07-01The anticipated "tripledemic" during the 2023-2024 season-in which simultaneous epidemics of SARS‑CoV‑2, influenza, and respiratory syncytial virus were projected-ultimately fell short of early forecasts. Nevertheless, each virus remains a significant public health concern in its own right. This article reviews the microbiology, diagnosis, and treatment of these three pathogens (including the role of immunomodulatory therapies), as well as key considerations for hospital infection prevention in the care of critically ill patients. The piece highlights the clinical indistinguishability of these viral infections and acknowledges the evolving public health discourse surrounding the role of vaccination in preventing disease.
-
4. Antibiotic Stewardship for the Intensivist.
PMID:日期:2026-07-01Intensive care units (ICUs) care for the most severely ill patients and consequently account for the largest volume of antibiotic use in the hospital. Critically ill patients must receive optimal, timely empiric antibiotic therapy. However, there are opportunities to improve overall antibiotic use in the ICU by ensuring that antibiotics are de-escalated based on culture and clinical data or stopped if an alternative, noninfectious diagnosis is determined. Further, shorter durations of therapy based on clinical trials should be selected to minimize antibiotic exposure. ICUs should work with hospital antibiotic stewardship programs to review antibiotic use and determine areas for improvement.
-
5. Infection Prevention and Control in the Intensive Care Unit.
PMID:日期:2026-07-01Health care-associated infections are common and burdensome in intensive care units, contributing to increased costs, morbidity, and mortality. The coronavirus disease 2019 (COVID-19) pandemic led to an increase in the incidence of intensive care unit (ICU)-acquired infections and multidrug-resistant organisms (MDROs), highlighting the urgent need for effective prevention strategies. This article summarizes core infection prevention practices in the ICU, examines risk factors, reviews approaches to limit the spread of MDROs and explores innovations in infection prevention.
-
6. Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.
PMID:日期:2026-07-01Treating infections in critically ill patients is uniquely challenging because of diverse disease states, high rates of antimicrobial resistance, pharmacokinetic changes, and a high risk of mortality that leaves little margin for error. Optimal management requires balancing early, appropriate antimicrobial therapy with risks of toxicity and resistance. To do so, clinicians must integrate microbiologic diagnostics, pathogen epidemiology, patient-specific risk factors, and local resistance rates with an understanding of antimicrobial agents' spectrum and pharmacologic properties and patients' altered pharmacokinetics and pharmacodynamics.
-
7. Recognizing and Managing Hemophagocytic Lymphohistiocytosis in Adults in the Intensive Care Unit.
PMID:日期:2026-07-01Hemophagocytic lymphohistiocytosis is a life-threatening hyperinflammatory syndrome increasingly recognized across age groups. This syndrome is driven by pathologic interferon-γ production, which leads to a self-sustaining positive feedback loop resulting in multi-organ dysfunction with a high mortality. Early recognition is essential, and clinical evaluation should prioritize identifying any predisposing diseases and acute triggers. Treatment requires a multi-faceted approach, including dampening the hyperinflammation, eliminating acute triggers and infectious complications, and optimizing management of all underlying predispositions. Novel prognostic markers (C-X-C motif ligand-9), and cytokine-directed therapies (ruxolitinib, emapalumab) show promise to help improve outcomes of patients with these complex hyperinflammatory syndromes in the future.
-
8. Lower Respiratory Tract Infections: Precision Diagnostics.
PMID:日期:2026-07-01Lower respiratory tract infections are the most common cause of death globally, representing the leading source of infection among patients admitted to the intensive care unit. Rapid and accurate pathogen identification allows a targeted therapy, yet most diagnostic tests require an extended processing time that can be detrimental in critically ill patients. New molecular and microbiological tools are now routinely available for precise pathogen identification, although important limitations remain that must be known prior to their use and when interpreting their results.
-
9. Optimal Approach to Source Control in Intensive Care Unit Patients.
PMID:日期:2026-07-01Source control is a cornerstone of managing infections and sepsis in the intensive care unit, requiring rapid recognition of infection, targeted diagnostic evaluation, and timely procedural or surgical intervention. This article presents a systems-based approach to identifying infection sources in critically ill patients through clinical assessment, targeted imaging, laboratory testing, and multidisciplinary collaboration. It outlines indications for conservative versus operative management across multiple organ systems. Emphasis is placed on early detection, anatomically focused intervention, prompt drainage of closed-space infections, judicious antibiotic use, and the role of coordinated care among intensivists, surgeons and proceduralists, and infectious disease specialists to optimize outcomes.
-
10. The Global Intensive Care Unit: Human Immunodeficiency Virus, Tuberculosis, and Malaria.
PMID:日期:2026-07-01More than 80% of the world's population lives in low-income and middle-income countries, yet access to critical care remains limited in these regions. Infectious diseases, especially human immunodeficiency virus, tuberculosis, and malaria, remain leading causes of critical care admissions and are associated with high mortality. Early recognition and timely initiation of appropriate therapies are important in improving outcomes. In this article, we aim to highlight the burden of disease, clinical presentation, diagnostic strategies, and management principles for these diseases in critically ill patients.